What is MaRS EXCITE?

As part of the MaRS Health services, the MaRS Excellence in Clinical Innovation Technology Evaluation (EXCITE) program is a collaboration between a range of stakeholders in the health system that work together to help innovative health technologies get to market faster and improve patient outcomes.

At the end of the program, companies will have a robust evidence package, called the EXCITE core evidentiary bundle, that they can use for both Health Canada licensing and reimbursement and purchasing reviews.

 
Beside device

  • Happy Holidays from EXCITE More...
  • Registration is now open for World Congress on Medical Physics and Biomedical Engineering More...
  • Need Funding? Apply for the OBIO Capital Access Advisory Program More...
  • Market Access for Medical Devices Webinar More...
  • CIMTEC Webinar – Clinical Trials 101 More...
  • CAHO Supports Ontario’s Continued Investment in Innovation and Health Innovation Leadership More...
  • Canadian Federal Healthcare Innovation Panel More...
  • CADTH announces plans to update guidelines for Economic Evaluation of Health Technologies More...
  • Health Minister Dr. Eric Hoskins’ Fall Newsletter More...
  • Learn: Why we need Economic Evaluation and Outcomes Research More...